Clomidep 25 mg FC tablets
PDF Leaflet Revision Date: 13 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depressive episodes, cataplexy, and obsessive-compulsive syndromes.
Dosage (summary)
Adults: 25 mg 2-3 times daily, max 250 mg. Elderly: Start at 10 mg, max 50 mg. Children: Start at 25 mg, max 3 mg/kg or 100-200 mg.
Special Populations
- Elderly
- Children (5 years and older)
Pregnancy & Breastfeeding
Not established for safety in pregnancy; contraindicated in breastfeeding.
Key Drug Interactions
- MAO-inhibitors
- SSRIs
- CNS depressants
- Anticholinergic agents
Contraindications
- Hypersensitivity to clomipramine
- Recent myocardial infarction
- Congenital long QT syndrome
- Hypokalaemia
Common side effects
- Drowsiness
- Dizziness
- Weight gain
- Dry mouth
Counselling Points
- Avoid alcohol
- Monitor for worsening depression
- Do not drive until effects are known
Serious warnings
- Risk of suicide
- QTc prolongation
- Serotonin syndrome
Important Disclaimer
The Clomidep 25 mg FC tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
